Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS9 | O00182 | 4/20 | 0.55 |
| ▸ | LGALS1 | P09382 | 4/20 | 0.55 |
| ▸ | LGALS3 | P17931 | 4/20 | 0.55 |
| ▸ | LGALS7; LGALS7B | P47929 | 3/20 | 0.55 |
| ▸ | SLC5A2 | P31639 | 4/20 | 0.47 |
| ▸ | MAOB | P27338 | 1/20 | 0.45 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.45 |
| ▸ | SLC5A1 | P13866 | 1/20 | 0.45 |
| ▸ | SLC28A3 | Q9HAS3 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tremuldin SCHEMBL29402284 | 1.00 | LGALS9 (0.55) | LGALS9LGALS1LGALS3LGALS7; LGALS7BSLC5A2 | |
| Itoside A SCHEMBL31677404 | 0.88 | LGALS9 (0.50) | LGALS9LGALS1LGALS3LGALS7; LGALS7BSLC5A2 | |
| SCHEMBL30527846 | 0.86 | SLC5A2 (0.51) | LGALS9LGALS1LGALS3LGALS7; LGALS7BSLC5A2 | |
| SCHEMBL1075010 | 0.86 | SLC28A3 (0.49) | LGALS9LGALS1LGALS3LGALS7; LGALS7BSLC5A2 | |
| SCHEMBL11368063 | 0.82 | LGALS3 (0.60) | LGALS9LGALS1LGALS3LGALS7; LGALS7BMAOB | |
| SCHEMBL11371729 | 0.82 | LGALS3 (0.60) | LGALS9LGALS1LGALS3LGALS7; LGALS7BMAOB | |
| SCHEMBL7528893 | 0.81 | LGALS9 (0.59) | LGALS9LGALS1LGALS3LGALS7; LGALS7BMAOB | |
| SCHEMBL6888066 | 0.80 | TYMP (0.44) | LGALS9LGALS1LGALS3LGALS7; LGALS7BSLC5A2 | |
| SCHEMBL18114326 | 0.79 | LGALS3 (0.57) | LGALS9LGALS1LGALS3LGALS7; LGALS7BMAOB | |
| SCHEMBL11380069 | 0.79 | LGALS3 (0.66) | LGALS9LGALS1LGALS3LGALS7; LGALS7BMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1718270-A1 | USE OF (2-HYDROXYPHENYL) ALCOHOLS, AND COSMETIC OR THERAPEUTIC FORMULATIONS CONTAINING SAID COMPOUNDS | Symrise GmbH & Co. KG (DE) | 2006-11-08 | — | — | EP | claimed |
| WO-2005079743-A1 | USE OF (2-HYDROXYPHENYL) ALCOHOLS, AND COSMETIC OR THERAPEUTIC FORMULATIONS CONTAINING SAID COMPOUNDS | SYMRISE GMBH & CO. KG (DE) | 2005-09-01 | — | — | WO | claimed |
| US-20250041374-A1 | WILLOW EXTRACT AND ITS USE IN TREATING A VIRAL INFECTION, ALLERGIC REACTION, AND OTHER MEDICAL CONDITIONS | SHIREEN NATURE COMPANY FOR GENERAL TRADING LTD. (IQ) | 2025-02-06 | — | — | US | disclosed |
| US-12029772-B2 | Willow extract and its use in treating a viral infection, allergic reaction, and other medical conditions | BARZANI, Mustafa (US) | 2024-07-09 | — | — | US | disclosed |
| EP-4313097-A1 | WILLOW EXTRACT AND ITS USE IN TREATING CORONAVIRUS INFECTION, INFLAMMATION, AND ASSOCIATED MEDICAL CONDITIONS | Shireen Nature Company for General Trading, Ltd. (IQ) | 2024-02-07 | — | — | EP | disclosed |
| US-20220323531-A1 | WILLOW EXTRACT AND ITS USE IN TREATING A VIRAL INFECTION, ALLERGIC REACTION, AND OTHER MEDICAL CONDITIONS | SHIREEN NATURE COMPANY FOR GENERAL TRADING LTD. (IQ) | 2022-10-13 | — | — | US | disclosed |
| WO-2022212314-A1 | WILLOW EXTRACT AND ITS USE IN TREATING CORONAVIRUS INFECTION, INFLAMMATION, AND ASSOCIATED MEDICAL CONDITIONS | SHIREEN NATURE COMPANY FOR GENERAL TRADING, LTD. (IQ) | 2022-10-06 | — | — | WO | disclosed |
| US-7868226-B2 | Poplar transcription factors | UNIVERSITY OF VICTORIA INNOVATION AND DEVELOPMENT CORPORATION (CA) | 2011-01-11 | — | — | US | disclosed |
| US-7714192-B2 | regulate the proanthocynanidin biosynthetic pathway and proanthocynanidin biosynthesis in a plant; genetic engineering; | UNIVERSITY OF VICTORIA INNOVATION AND DEVELOPMENT CORPORATION (CA) | 2010-05-11 | — | — | US | disclosed |
| US-20100074995-A1 | POPLAR TRANSCRIPTION FACTORS | UNIVERSITY OF VICTORIA INNOVATION AND DEVELOPMENT CORPORATION | 2010-03-25 | — | — | US | disclosed |
| US-20090165169-A1 | POPLAR TRANSCRIPTION FACTORS | UNIVERSITY OF VICTORIA INNOVATION AND DEVELOPMENT CORPORATION | 2009-06-25 | — | — | US | disclosed |
| CN-1933801-A | Use of (2-hydroxyphenyl) alcohols and cosmetic or therapeutic preparations containing said compounds | SYMRISE GMBH & CO KG (DE) | 2007-03-21 | — | — | CN | disclosed |
| EP-1718270-A1 | USE OF (2-HYDROXYPHENYL) ALCOHOLS, AND COSMETIC OR THERAPEUTIC FORMULATIONS CONTAINING SAID COMPOUNDS | Symrise GmbH & Co. KG (DE) | 2006-11-08 | — | — | EP | disclosed |
| WO-2005079743-A1 | USE OF (2-HYDROXYPHENYL) ALCOHOLS, AND COSMETIC OR THERAPEUTIC FORMULATIONS CONTAINING SAID COMPOUNDS | SYMRISE GMBH & CO. KG (DE) | 2005-09-01 | — | — | WO | disclosed |